Previous 10 | Next 10 |
The biggest risk with Hologic today is the uncertain path for COVID-19 testing; expanding vaccination rates are driving sharp declines in testing that accounted for almost half of FQ1'21 revenue. Whatever the decline path for COVID-19 testing is, the pandemic drove a significant incre...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While you might not want to hear it, given we’re still in the global grip of Covid-19, it must be said: more pandemics are coming . How much they will impact our day-to-day lives remains to be seen, but our curren...
FinancialBuzz.com News Commentary New York, NY (3/31/2021) – The pandemic is still a very real threat as the number of new cases spiked in the United States once again. Data provided by Johns Hopkins University indicates that U.S has averaged 65,700 new cases a day over the last ...
According to Stock Traders Daily, a 2-year industry veteran, investors can use the price action in Hologic (NASDAQ: HOLX) to foretell upcoming changes. A current example is provided below. There are trading plans for HOLX, but the data on this page does not update in real time. If...
-- First Time Named to Top List of Highly Engaged Companies -- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has been named a winner of the 2021 Gallup Exceptional Workplace Award, the Company announced today. This prestigious award recognizes the most eng...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. Focus on XBI. For further details see: Healthcare Dashboard For March And Focus On XBI
When influential investors make decisions to buy and sell securities, they normally want to keep it quiet. However, if we pay close attention we can see what is going on, and make good decisions.. The Hologic (NASDAQ: HOLX) report below can help you understand how to do this. The ...
The FDA today said it has established a streamlined process for companies that want to gain emergency use authorization (EUA) for COVID-19 tests of asymptomatic individuals.The first part is a supplemental template that outlines the data and information that should be submitted to the FD...
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Hologic (NASDAQ: HOLX) Empower Clinics (OTC: EPWCF) (CSE: CBDT), Oak Street Health (NYSE: OSH), Reliq ...
What was once a leading women's healthcare company got a boost from the pandemic due to COVID testing. Hologic (HOLX) has a leading position in many testing areas and is poised to gain from international expansion. Read more to learn why this stock belongs in your portfolio. Hologic ( ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...